无码欧美成人av天堂456软件,大胆日本熟妇XXXX,9277在线观看免费播放,4p三个男人让我爽了一夜

產(chǎn)品訂購信息：
英文名稱  Anti-Nucleophosmin 

中文名稱   核仁磷酸蛋白抗體品牌 

別    名  B23; B23; MGC104254; NMP1; NMP1; NO38; NPM 1; NPM; NPM_HUMAN; NPM1; Nucleolar Phosphoprotein B23; Nucleolar Phosphoprotein B23; Nucleolar protein NO38; Nucleophosmin (nucleolar phosphoprotein B23 numatrin); Nucleophosmin; Nucleophosmin/B23.2; Nucleophosmin/nucleoplasmin family member 1; Nucleoplasmin Family Member 1; Nucleoplasmin Family Member 1; Numatrin; Numatrin; OTTHUMP00000161024; OTTHUMP00000161025; OTTHUMP00000223397; OTTHUMP00000223398; TRK fused gene.

濃    度   1mg/1ml

規(guī) 格  0.1ml/100μg 0.2ml/200μg

抗體來源   Rabbit

克隆類型   polyclonal

交叉反應(yīng)   Human, Mouse, Rat, Dog, Pig, Cow, Horse, Rabbit 

產(chǎn)品類型   一抗  

研究領(lǐng)域    細(xì)胞生物 免疫學(xué) 表觀遺傳學(xué)

蛋白分子量  predicted molecular weight: 33kDa

性    狀   Lyophilized or Liquid

免 疫 原 KLH conjugated synthetic peptide derived from human Nucleophosmin 

亞    型   IgG

純化方法   affinity purified by Protein A

儲(chǔ) 存 液   Preservative: 15mM Sodium Azide, Constituents: 1% BSA, 0.01M PBS, pH 7.4

核仁磷酸蛋白抗體品牌 產(chǎn)品應(yīng)用    WB=1:100-500 ELISA=1:500-1000 IHC-P=1:100-500 IHC-F=1:100-500 IF=1:50-200

（石蠟切片需做抗原修復(fù)） 

 not yet tested in other applications.

 optimal dilutions/concentrations should be determined by the end user.  

保存條件  Store at -20 °C for one year. Avoid repeated freeze/thaw cycles. The lyophilized antibody is stable at room temperature for at least one month and for greater than a year when kept at -20°C. When reconstituted in sterile pH 7.4 0.01M PBS or diluent of antibody the antibody is stable for at least two weeks at 2-4 °C. 

Important Note  This product as supplied is intended for research use only, not for use in human, therapeutic or diagnostic applications. 

產(chǎn)品介紹 This gene encodes a phosphoprotein which moves between the nucleus and the cytoplasm. The gene product is thought to be involved in several processes including regulation of the ARF/p53 pathway. A number of genes are fusion partners have been characterized, in particular the anaplastic lymphoma kinase gene on chromosome 2. Mutations in this gene are associated with acute myeloid leukemia. More than a dozen pseudogenes of this gene have been identified. Alternative splicing results in multiple transcript variants.[provided by RefSeq, Nov 2009].

Function : Involved in diverse cellular processes such as ribosome biogenesis, centrosome duplication, protein chaperoning, histone assembly, cell proliferation, and regulation of tumor suppressors p53/TP53 and ARF. Binds ribosome presumably to drive ribosome nuclear export. Associated with nucleolar ribonucleoprotein structures and bind single-stranded nucleic acids. Acts as a chaperonin for the core histones H3, H2B and H4. Stimulates APEX1 endonuclease activity on apurinic/apyrimidinic (AP) double-stranded DNA but inhibits APEX1 endonuclease activity on AP single-stranded RNA. May exert a control of APEX1 endonuclease activity within nucleoli devoted to repair AP on rDNA and the removal of oxidized rRNA molecules.Subunit : Decamer formed by two pentameric rings associated in a head-to-head fashion. Disulfide-linked dimers under certain conditions. The SWAP complex consists of NPM1, NCL, PARP1 and SWAP70 (By similarity). Interacts with NSUN2 and SENP3. Interacts with hepatitis delta virus S-HDAg. Interacts with HTLV1 Rex protein (via N-terminal nuclear localization signal). Interacts with the methylated form of RPS10. Interacts (via N-terminal domain) with APEX1; the interaction is RNA-dependent and decreases in hydrogen peroxide-damaged cells.Subcellular Location : Nucleus, nucleolus. Nucleus, nucleoplasm. Note=Generally nucleolar, but is translocated to the nucleoplasm in case of serum starvation or treatment with anticancer drugs. Has been found in the cytoplasm in patients with primary acute myelogenous leukemia (AML), but not with secondary AML. Can shuttle between cytoplasm and nucleus. Co-localizes with the methylated form of RPS10 in the granular component (GC) region of the nucleolus. Colocalized with nucleolin and APEX1 in nucleoli.Post-translational modifications : Acetylated at C-terminal lysine residues, thereby increasing affinity to histones.ADP-ribosylated.Phosphorylated at Ser-4 by PLK1. Phosphorylated by CDK2 at Ser-125 and Thr-199. Phosphorylation at Thr-199 may trigger initiation of centrosome duplication. Phosphorylated by CDK1 at Thr-199, Thr-219, Thr-234 and Thr-237 during cell mitosis. When these four sites are phosphorated, RNA-binding activity seem to be abolished. May be phosphorylated at Ser-70 by NEK2.Sumoylated by ARF.DISEASE : Note=A chromosomal aberration involving NPM1 is found in a form of non-Hodgkin lymphoma. Translocation t(2;5)(p23;q35) with ALK. The resulting chimeric NPM1-ALK protein homodimerize and the kinase becomes constitutively activated.Note=A chromosomal aberration involving NPM1 is found in a form of acute promyelocytic leukemia. Translocation t(5;17)(q32;q11) with RARA.Note=A chromosomal aberration involving NPM1 is a cause of myelodysplastic syndrome (MDS). Translocation t(3;5)(q25.1;q34) with MLF1.Note=Defects in NPM1 are associated with acute myelogenous leukemia (AML). Mutations in exon 12 affecting the C-terminus of the protein are associated with an aberrant cytoplasmic location.Similarity : Belongs to the nucleoplasmin family.Database links : UniProtKB/Swiss-Prot: P06748.2

Integrin a7(integrin alpha 7) 整合素α7抗原Multi-class antibodies規(guī)格： 0.5mg

Anti-Integrin Alpha V 整合素αV抗體Multi-class antibodies規(guī)格： 0.2ml

Rhesus antibody Rh Phospho-CD19(Tyr531) 磷酸化CD19抗體 規(guī)格 0.1ml

TMB單組份染色液 100ml/500ml 用于ELISA

VGLL4 英文名稱： 轉(zhuǎn)錄輔助因子退變樣蛋白4抗體 0.2ml

Dnmt3L 英文名稱： DNA甲基轉(zhuǎn)移酶3L抗體 0.2ml

Anti-Integrin Alpha V 整合素αV抗體Multi-class antibodies規(guī)格： 0.2ml

GDNF 人神經(jīng)膠質(zhì)細(xì)胞系衍化神經(jīng)營(yíng)養(yǎng)因子Multi-class antibodies規(guī)格： 48T

Anti-Cyclin A 周期素A抗體Multi-class antibodies規(guī)格： 0.1ml

Rhesus antibody Rh NGALR/Slc22A17 可溶性載質(zhì)轉(zhuǎn)運(yùn)蛋白22A17抗體 規(guī)格 0.1ml

Human adaptor molecule apoptotic peptidase activating factor 1,APAF1 ELISA Kit 人銜接蛋白酶活化因子1 96T

TLR4 英文名稱： Toll樣受體4抗體 0.1ml

Phospho-CHK2 (Ser28) 英文名稱： 磷酸化細(xì)胞周期檢測(cè)點(diǎn)激酶2抗體 0.1ml

Anti-Cyclin A 周期素A抗體Multi-class antibodies規(guī)格： 0.1ml

IL-12/P40 ELISA Kit 大鼠白介素12Multi-class antibodies規(guī)格： 48T

Anti-beta Adaptin/AP2/FITC 熒光素標(biāo)記銜接蛋白β抗體IgGMulti-class antibodies規(guī)格： 0.2ml

Rhesus antibody Rh FAM82B 微管相關(guān)蛋白FAM82B抗體 規(guī)格 0.2ml

MIP-5(Human macrophage inflammatory protein 5) ELISA Kit 人巨噬細(xì)胞炎性蛋白5 96T

MS4A2 英文名稱： 跨膜結(jié)構(gòu)域4亞家族成員2抗體 0.2ml

phospho-Acinus (Ser1180) 英文名稱： 磷酸化腺泡Acinus蛋白抗體 0.1ml

Anti-beta Adaptin/AP2/FITC 熒光素標(biāo)記銜接蛋白β抗體IgGMulti-class antibodies規(guī)格： 0.2ml

BMP5 Protein Human 重組人 BMP-5 蛋白 (Fc 標(biāo)簽)

Calu-1 人細(xì)胞

PROCR Others Mouse 小鼠 Epcr / PROCR 人細(xì)胞裂解液 (陽性對(duì)照)

CFPAC-1人*癌細(xì)胞 Human pancreatic cancer cell line CFPAC-1 IMDM(GIBCO)+10%FBS

615小鼠株;Ca763

人肝星形細(xì)胞 (HHSteC)( 5×105 ) COS-7L, 非洲綠猴腎成纖維細(xì)胞 其它

CM-H003人肺大動(dòng)脈平滑肌細(xì)胞完全培養(yǎng)基100mL

NGFR Others Human 人 NGFR/ P75 人細(xì)胞裂解液 (陽性對(duì)照)

I型膠原酶(含10mL酶解緩沖液) 1mL

CAL 27-EGFP(CMV-EGFP慢病毒構(gòu)建穩(wěn)定株)人舌鱗癌細(xì)胞 CAL 27-EGFP (CMV-EGFP leiviral consuct stable sain) of human tongue squamous cell carcinoma DMEM+10% FBS

IL21 Protein Mouse 重組小鼠 IL21 / Ierleukin 21 蛋白

人表皮黑色素細(xì)胞-深色素(HEM)( 5×105 ) MN-h, 小鼠海馬神經(jīng)元 Mouse

核仁磷酸蛋白抗體品牌 BMP5 Protein Human 重組人 BMP-5 蛋白 (Fc 標(biāo)簽)

Calu-1 人細(xì)胞

PROCR Others Mouse 小鼠 Epcr / PROCR 人細(xì)胞裂解液 (陽性對(duì)照)

CFPAC-1人*癌細(xì)胞 Human pancreatic cancer cell line CFPAC-1 IMDM(GIBCO)+10%FBS

615小鼠株;Ca763

人肝星形細(xì)胞 (HHSteC)( 5×105 ) COS-7L, 非洲綠猴腎成纖維細(xì)胞 其它

抗體的生物素化標(biāo)記實(shí)驗(yàn)要點(diǎn)：

1. 核仁磷酸蛋白抗體品牌 如在反應(yīng)混合液中有疊氮鈉或游離氨基存在,會(huì)抑制標(biāo)記反應(yīng)。因此,蛋白質(zhì)在反應(yīng)前要對(duì) 0.1mol/L碳酸氫鈉緩沖液或0.5mol/L硼酸緩沖液充分透析；

2.所用的NHSB及待生物素化蛋白質(zhì)之間的分子比按蛋白質(zhì)表面的ε-氨基的密度會(huì)有所不同,選擇不當(dāng)則影響標(biāo)記的效率,應(yīng)先用幾個(gè)不同的分子比來篩選最適條件；

3.用NHSB量過量也是不利的,抗原的結(jié)合位點(diǎn)可能因此被封閉,導(dǎo)致抗體失活；

4.由于抗體的氨基不易接近可能造成生物素化不足,此時(shí)可加入去污劑如 Triton x-100, Tween20等；

5.當(dāng)游離ε-氨基(賴氨酸殘基的氨基)存在于抗體的抗原結(jié)合位點(diǎn)時(shí),或位于酶的催化位點(diǎn)時(shí),生物素化會(huì)降低或損傷抗體蛋白的結(jié)合力或活性；

6.生物素還可能與不同的功能基團(tuán),如羰基、氨基、巰基、異咪唑基及苯酚基,也可與糖基共價(jià)結(jié)合；

7.交聯(lián)反應(yīng)后,應(yīng)充分透析,否則,殘余的生物素會(huì)對(duì)生物素化抗體與親和素的結(jié)合產(chǎn)生競(jìng)爭(zhēng)作用；

8.在細(xì)胞的熒光標(biāo)記實(shí)驗(yàn)中,中和親和素的本底低,但由于鏈霉親和素含有少量正電荷,故對(duì)某些細(xì)胞可導(dǎo)致高本底。

抗體的鑒定：

1）核仁磷酸蛋白抗體品牌 抗體的效價(jià)鑒定：不管是用于診斷還是用于,制備抗體的目的都是要求較高效價(jià)。不同的抗原制備的抗體,要求的效價(jià)不一。鑒定效價(jià)的方法很多,包括有試管凝集反應(yīng),瓊脂擴(kuò)散試驗(yàn),酶聯(lián)免疫吸附試驗(yàn)等。常用的抗原所制備的抗體一般都有約成的鑒定效價(jià)的方法,以資比較。如制備抗抗體的效價(jià),一般就采用瓊脂擴(kuò)散試驗(yàn)來鑒定。

2）抗體的特異性鑒定：抗體的特異性是指與相應(yīng)抗原或近似抗原物質(zhì)的識(shí)別能力。抗體的特異性高,它的識(shí)別能力就強(qiáng)。衡量特異性通常以交叉反應(yīng)率來表示。交叉反應(yīng)率可用競(jìng)爭(zhēng)抑制試驗(yàn)測(cè)定。以不同濃度抗原和近似抗原分別做競(jìng)爭(zhēng)抑制曲線,計(jì)算各自的結(jié)合率,求出各自在IC50時(shí)的濃度,并按公式計(jì)算交叉反應(yīng)率。 

如果所用抗原濃度IC50濃度為pg/管,而一些近似抗原物質(zhì)的IC50濃度幾乎是無窮大時(shí),表示這一抗血清與其他抗原物質(zhì)的交叉反應(yīng)率近似為0,即該血清的特異性較好。

3）抗體親和力：是指抗體和抗原結(jié)合的牢固程度。親和力的高低是由抗原分子的大小,抗體分子的結(jié)合位點(diǎn)與抗原決定簇之間立體構(gòu)型的合適度決定的。有助于維持抗原抗體復(fù)合物穩(wěn)定的分子間力有氫鍵,疏水鍵,側(cè)鏈相反電荷基因的庫侖力,范德華力和空間斥力。親和力常以親和常數(shù)K表示,K的單位是L/mol。抗體親和力的測(cè)定對(duì)抗體的篩選,確定抗體的用途,驗(yàn)證抗體的均一性等均有重要意義。